News and Trends 23 Mar 2015
AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome
AOP Orphan Pharmaceuticals and Confluence Pharmaceuticals, signed today a definitive agreement to co-develop and market Confluence’s lead asset, a product…